These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22772325)

  • 1. Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman.
    Martínez-Martínez MU; Baranda-Cándido L; González-Amaro R; Pérez-Ramírez O; Abud-Mendoza C
    Rheumatology (Oxford); 2013 Feb; 52(2):405-6. PubMed ID: 22772325
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura.
    Gall B; Yee A; Berry B; Bircham D; Hayashi A; Dansereau J; Hart J
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1167-1171. PubMed ID: 21176329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development.
    Klink DT; van Elburg RM; Schreurs MW; van Well GT
    Clin Dev Immunol; 2008; 2008():271363. PubMed ID: 18596903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of rituximab in resistant thrombocytopenic purpura].
    Zambrano-Velarde MA; de la O-Peña D; Chávez-Peña Q; Bedolla-Barajas M
    Rev Med Inst Mex Seguro Soc; 2012; 50(2):203-8. PubMed ID: 22882991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of refractory immune thrombocytopenia with rituximab in a 10-week-old infant.
    Gray C; Kalumba K; Pati N; Peterson A; Connell TG
    J Pediatr Hematol Oncol; 2013 May; 35(4):e174-7. PubMed ID: 23459375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Commentary on "Rituximab in thrombocytopenic purpura..."].
    García-Álvarez JL
    Rev Med Inst Mex Seguro Soc; 2012; 50(4):351-2. PubMed ID: 23234734
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reply to commentary on "Rituximab in thrombocytopenic purpura..."].
    Zambrano-Velarde MA; de la O-Peña D; Chávez-Peña Q; Bedolla-Barajas M
    Rev Med Inst Mex Seguro Soc; 2012; 50(4):353-4. PubMed ID: 23234735
    [No Abstract]   [Full Text] [Related]  

  • 8. B-cell depletion in immune thrombocytopenia.
    Psaila B; Cooper N
    Lancet; 2015 Apr; 385(9978):1599-601. PubMed ID: 25662418
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent memory B cell down-regulation after 6-year remission induced by rituximab therapy in patients with systemic lupus erythematosus.
    Iwata S; Saito K; Tokunaga M; Tanaka Y
    Lupus; 2013 Apr; 22(5):538-40. PubMed ID: 23423251
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia.
    Oo TH
    South Med J; 2005 Dec; 98(12):1227-8. PubMed ID: 16440930
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of rituximab and dexamethasone on regulatory and proinflammatory B-cell subsets in patients with primary immune thrombocytopenia.
    Gudbrandsdottir S; Brimnes M; Køllgaard T; Hasselbalch HC; Nielsen CH
    Eur J Haematol; 2018 Jan; 100(1):45-52. PubMed ID: 28960473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.
    Zwaginga JJ; van der Holt B; Te Boekhorst PA; Biemond BJ; Levin MD; van der Griend R; Brand A; Zweegman S; Pruijt HF; Novotny VM; Vreugdenhil A; de Groot MR; de Weerdt O; van Pampus EC; van Maanen-Lamme TM; Wittebol S; Schipperus MR; Silbermann MH; Huijgens PC; Luten M; Hollestein R; Brakenhoff JA; Schrama JG; Valster FA; Velders GA; Koene HR;
    Haematologica; 2015 Mar; 100(3):e90-2. PubMed ID: 25425692
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis.
    Thude H; Gruhn B; Werner U; Schorner U; Häfer R; Zintl F; Barz D
    Acta Haematol; 2004; 111(4):221-4. PubMed ID: 15153715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy.
    Shores D; Kobak G; Pegram LD; Whitington PF; Shneider BL
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):e128-30. PubMed ID: 21921813
    [No Abstract]   [Full Text] [Related]  

  • 15. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent infections in an ITP patient treated with rituximab].
    Rosenberg-Bezalel S; Asher I; Sthoeger Z
    Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
    Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Isola M; Buttignol S; Fanin R
    Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Persistent hypogammaglobulinemia in an ITP patient following treatment with rituximab].
    Toubi E
    Harefuah; 2012 Nov; 151(11):620-1, 655. PubMed ID: 23367731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for patients with idiopathic thrombocytopenic purpura.
    Peñalver FJ; Cabrera JR
    Ann Intern Med; 2007 Aug; 147(4):281; author reply 281-2. PubMed ID: 17709765
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children.
    Roganovic J
    Eur J Pediatr; 2005 May; 164(5):334. PubMed ID: 15711954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.